Physician profile
Mohammad Saeed
NPI 1063588358
$21,941.25
in general payments reported to CMS, 2019-2025
26 companies · $2,576 in 2025
The $2,576 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,073 · 2020: $2,931 · 2021: $1,233 · 2022: $3,914 · 2023: $6,842 · 2024: $1,372 · 2025: $2,576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Food and Beverage: $4,537 · Travel and Lodging: $1,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Food and Beverage | $4,537.42 |
| Travel and Lodging | $1,252.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,508.41 | 2019-2025 | Aveir, Assurity, Gallant |
| Boston Scientific Corporation | $6,227.85 | 2019-2025 | Rhythmia Mapping System, Mylux Patient Kit With Mobile Device, S-Icd System Magnet |
| Biosense Webster, INC. | $3,669.89 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Medtronic, INC. | $783.35 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Ellipsys Vascular Access System |
| Impulse Dynamics (USA) INC. | $577.53 | 2021-2024 | Optimizer, Optimizer |
| Pfizer INC. | $194.75 | 2019-2023 | |
| Medtronic Vascular, INC. | $166.76 | 2019 | |
| Janssen Pharmaceuticals, INC | $129.61 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $109.58 | 2024-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $82.55 | 2022-2025 | |
| Aroa Biosurgery Incorporated | $78.36 | 2025 | |
| Irhythm Technologies, INC. | $56.29 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Cardiva Medical, INC. | $54.17 | 2022 | |
| Novartis Pharmaceuticals Corporation | $45.97 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $39.03 | 2022-2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $30.80 | 2021 | |
| Itamar Medical INC | $29.38 | 2022 | |
| Baxter Healthcare | $24.83 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.13 | 2019-2025 | Lifevest |
| Circa Scientific, INC. | $20.34 | 2025 | |
| Bardy Diagnostics, INC. | $20.00 | 2019 | |
| Philips North America LLC | $17.23 | 2019 | |
| Cook Medical LLC | $14.83 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.47 | 2023 | Jardiance |
| Vektor Medical INC. | $12.53 | 2024 | Vmap |
| Elutia, INC. | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Saeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.